Popular on eTradeWire
- K9 Technology President Files a Lawsuit Against Google LLC - 284
- BK Adventure Celebrates 10 Years of Glow: Join the Year-Long Celebration! - 237
- NCYS Names Distinguished Sports Leaders to Officer Positions for 2025 - 224
- Premium workspaces with exceptional hospitality to fuel your growth. Where professionals thrive - 203
- Uriel Medrano Joins RE1 Advisor as Property Manager/Realtor - 199
- The Perfect Book for Your Child's First Lost Tooth! - 197
- CROW receives funding to rebuild Sea Turtle Complex post Hurricane Ian - 172
- Pet Professional Guild Announces Corporate Partnership with the Phenix Advocacy Center - 170
- Vocs AI Announces Three Groundbreaking Features to Revolutionize AI Voice Generation - 162
- Benchmark International Faciltd. the Trans BT EZ Fabricating, Inc. and House Rock Capital Partners - 146
Similar on eTradeWire
- Sano Chemicals Inc. (DBA "Sano Women's Health") Announces Approval to Start Phase 1 MAD Study
- Curtana Pharmaceuticals Announces Breakthrough in Pediatric Brain Cancer Treatment with Dual Studies Published in Nature Communications
- Manhattan BioSolutions Initiates NCI PIVOT Collaboration in Pediatric Cancers
- Improzo Inc. Making Waves in Healthcare with Tech-Driven Patient Focus
- Oak Therapeutics Develops Novel Oral Dissolvable Strips for Antiretroviral Therapy for Infants
- $27 Million Funding; Coverage on Sanjay Gupta/CNN for Treatment of Suicidal Depression; Nasdaq Tier Uplisting: NRx Pharmaceuticals: Stock Symbol: NRXP
- Performentor, LLC Announces 2025 Unleash People Energy® Award Winners
- Enter the Dragon - PermianMuseum.com adds a Winged Dragon Fossil
- OneSolution® Dental Implant Centers Celebrates Over 15,000 Successful Full-Arch Cases
- Ventura & Associates HTA Advisors Partners with Microsoft to Expand AI and Cloud Capabilities
Human Asialoglycoprotein Receptor 1 Extracellular Domain (recombinant)
eTradeWire News/10772123
SAN DIEGO - eTradeWire -- Human Asialoglycoprotein Receptor 1 Extracellular Domain (recombinant)
Human Asialoglycoprotein Receptor 1 Extracellular Domain (recombinant) is a high quality protein that is produced using genetic engineering techniques. This protein is a part of the human asialoglycoprotein receptor 1, which is a cell surface receptor involved in the recognition and clearance of glycoproteins from the bloodstream. The extracellular domain of this receptor is the part of the protein that is located outside of the cell and is responsible for binding to specific ligands. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.
Human Asialoglycoprotein Receptor 1 Extracellular Domain (recombinant)
Catalog number: B2016799
Lot number: Batch Dependent
Expiration Date: Batch dependent
More on eTradeWire News
Amount: 50 µg
Molecular Weight or Concentration: 28.8 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -80°C
Keywords: ASGPR1, ASGR1, C-type Lectin Domain Family 4 Member H1, CLEC4H1, Hepatic Lectin H1
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1: Wymann S, Mischnik M, Leong D, Ghosh S, Tan X, Cao H, Kuehnemuth B, Powers GA, Halder P, de Souza MJ, James HS, Tomasetig V, Lind H, Rossato P, Owczarek CM, Ow SY, Dower SK, Baz Morelli A, Rowe T, Hardy MP. Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity in vivo Biochem J. 2022 May 13;479(9):1007-1030.
https://moleculardepot.com/product/human-asialoglycoprotein-receptor-1-extracellular-domain-recombinant/
Human Asialoglycoprotein Receptor 1 Extracellular Domain (recombinant) is a high quality protein that is produced using genetic engineering techniques. This protein is a part of the human asialoglycoprotein receptor 1, which is a cell surface receptor involved in the recognition and clearance of glycoproteins from the bloodstream. The extracellular domain of this receptor is the part of the protein that is located outside of the cell and is responsible for binding to specific ligands. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.
Human Asialoglycoprotein Receptor 1 Extracellular Domain (recombinant)
Catalog number: B2016799
Lot number: Batch Dependent
Expiration Date: Batch dependent
More on eTradeWire News
- Equipment Finance Canada Offers Flexible Financing Solutions for Heavy Equipment
- Angel's Awesome Books Launches Positive Affirmation Journal for Kids with Autism Support
- KidsBliss and Taeocti Announce 'Summer & Snuggles' Giveaway
- The Jaime & Blanca Jarrín Foundation Golf Classic Raises Vital Funds for Southern California Wildfire Relief Efforts
- Cloud Dominates AI Deployment as Developers Leverage Scalable Environments
Amount: 50 µg
Molecular Weight or Concentration: 28.8 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -80°C
Keywords: ASGPR1, ASGR1, C-type Lectin Domain Family 4 Member H1, CLEC4H1, Hepatic Lectin H1
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1: Wymann S, Mischnik M, Leong D, Ghosh S, Tan X, Cao H, Kuehnemuth B, Powers GA, Halder P, de Souza MJ, James HS, Tomasetig V, Lind H, Rossato P, Owczarek CM, Ow SY, Dower SK, Baz Morelli A, Rowe T, Hardy MP. Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity in vivo Biochem J. 2022 May 13;479(9):1007-1030.
https://moleculardepot.com/product/human-asialoglycoprotein-receptor-1-extracellular-domain-recombinant/
Source: Molecular Depot
Filed Under: Biotech
0 Comments
Latest on eTradeWire News
- Global Digital Currency & Wealth Management Leader; Breakout 388% FY2025 Revenue Growth Over $19.7 Million: Metalpha Technology (Stock Symbol: MATH)
- Globally-Inspired Clean Beauty Line & Community Wellness Center Host Spring Wellness Event
- NETRF Opens Applications for 2025 Research Grants
- Georgia's Sip & Swine BBQ Festival to Celebrate Ten Tantalizing Years
- Breakaway Introduces New SAP Integration Agent for Enhanced Data Integration in GTN Platform
- Continuity & RAC Announce $500K ARPA Grant Recipients for STL Film Project
- Professional of air conditioning repair Aurora Colorado
- Grateful Hearts event raises $228,000 in support of Lee Health Heart Institute
- InterMountain Opens Urban Inspired Aloft Sacramento Airport Natomas
- OEM Technology Partnerships Launches Brokerage Specializing in 100+ OEM Technologies
- Popular Senior Housing Series Continues
- Restoring Excellence With Porche and Bennett Awards
- Second Annual Election Integrity Conference Scheduled for March 7th
- We are the ONLY nonprofit (501C3) who can make this education claim (due to our patented product)
- Riverdale awarded grant to boost community tree canopy
- Romantic ballad by Nyasia Chane'l Featured in Rising Indie Filmmaker Tracey Parson's Film "Unexposed"
- ROC Celebrates 1,000 Robotic Knee Replacements Using the ROSA™ Robotic Knee System
- RNGD Opens New Headquarters Campus, Connecting Construction Operations, Manufacturing Operations and Training Center
- Kelly Sue Milano, co-creator of Hex11, joins Immortal Studios as VP of content and executive editor of the Immortal Storyverse
- Visit CAS DataLoggers at Pittcon 2025